We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Fewer than 10% of primary care physicians have received approval from the federal government to prescribe the opioid addiction medication buprenorphine, according to a study published in Annals of Internal Medicine.
The annual Monitoring the Future survey has found U.S. teens are vaping more marijuana and nicotine than a year ago. The survey found 14% of 12th graders said they had vaped marijuana in the last month—almost double the percentage reported last year.
The cost of treating babies born with neonatal abstinence syndrome, who experience withdrawal after being exposed to opioids during pregnancy, was $573 million in 2016, according to a new study in JAMA Pediatrics.
A federal appeals court said this week that the U.S. Food and Drug Administration can regulate e-cigarettes like it does other tobacco products including conventional cigarettes, The Washington Post reports.
The drugs gabapentin and baclofen, both of which are sometimes prescribed instead of opioids for chronic pain, are increasingly being misused, according to a new report. The drugs are being used in a growing number of suicide attempts.